What it sells
Coherence designs therapeutic neurotechnology to manage cancer from inside the body; its flagship SOMA is a brain-computer interface with a wireless coin-sized implant, an over-ear wearable and an app that monitors disease and delivers stimulation.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-28 | Series A | $45M | Founders Fund (lead), OpenAI Startup Fund (lead) | pulse2.com |
| 2026-10-27 | — | $45M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-29.